148 related articles for article (PubMed ID: 32148016)
1. α
Zou Y; Sun Y; Guo B; Wei Y; Xia Y; Huangfu Z; Meng F; van Hest JCM; Yuan J; Zhong Z
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14905-14913. PubMed ID: 32148016
[TBL] [Abstract][Full Text] [Related]
2. Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
Zou Y; Meng F; Deng C; Zhong Z
J Control Release; 2016 Oct; 239():149-58. PubMed ID: 27569664
[TBL] [Abstract][Full Text] [Related]
3. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation
Wang Y; Guo M; Lin D; Liang D; Zhao L; Zhao R; Wang Y
Drug Deliv; 2021 Dec; 28(1):1510-1523. PubMed ID: 34263685
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.
Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z
J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor effect on intrapulmonary tumors of docetaxel lung-targeted liposomes in a rabbit model of VX2 orthotopic lung cancer.
Wang L; Li R; Che K; Liu Z; Xiang S; Li M; Yu Y
Sci Rep; 2017 Aug; 7(1):10069. PubMed ID: 28855665
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer.
Zhu X; Yu Z; Feng L; Deng L; Fang Z; Liu Z; Li Y; Wu X; Qin L; Guo R; Zheng Y
Carbohydr Polym; 2021 Sep; 268():118237. PubMed ID: 34127219
[TBL] [Abstract][Full Text] [Related]
8. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
Wang X; Cheng R; Zhong Z
Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
[TBL] [Abstract][Full Text] [Related]
9. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
[TBL] [Abstract][Full Text] [Related]
10. Cystine supplementation rebalances the redox homeostasis of microenvironment in non-small cell lung cancer cells and reverses their resistance to docetaxel.
Li SJ; Cao B; Lu ZY; Sun RB; Guo SH; Xie Y; Aa JY; Wang GJ
Acta Pharmacol Sin; 2021 Dec; 42(12):2132-2143. PubMed ID: 33658706
[TBL] [Abstract][Full Text] [Related]
11. CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors
Fang H; Zhao X; Gu X; Sun H; Cheng R; Zhong Z; Deng C
Biomacromolecules; 2020 Jan; 21(1):104-113. PubMed ID: 31532629
[TBL] [Abstract][Full Text] [Related]
12. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.
Xiao W; Ma W; Wei S; Li Q; Liu R; Carney RP; Yang K; Lee J; Nyugen A; Yoneda KY; Lam KS; Li T
J Hematol Oncol; 2019 Jun; 12(1):56. PubMed ID: 31182116
[TBL] [Abstract][Full Text] [Related]
13. Transferrin-Decorated Protein-Lipid Hybrid Nanoparticle Efficiently Delivers Cisplatin and Docetaxel for Targeted Lung Cancer Treatment.
Mao K; Zhang W; Yu L; Yu Y; Liu H; Zhang X
Drug Des Devel Ther; 2021; 15():3475-3486. PubMed ID: 34413632
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.
Tang N; Zhang Q; Fang S; Han X; Wang Z
Oncotarget; 2017 Feb; 8(6):9134-9143. PubMed ID: 27852073
[TBL] [Abstract][Full Text] [Related]
15. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
16. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Antitumor Efficacy of Docetaxel-Loaded Monomethoxy Poly(ethylene glycol)-Poly(D, L-lactide-co-glycolide) Amphiphilic Copolymer Against Non-Small Cell Lung Cancer.
Lin Y; Zhuang X; Xie B; Chen H
J Nanosci Nanotechnol; 2020 Dec; 20(12):7263-7270. PubMed ID: 32711589
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
19. DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer.
Jiang Y; Huang W; Sun X; Yang X; Wu Y; Shi J; Zheng J; Fan S; Liu J; Wang J; Liang Z; Yang N; Liu Z; Liu Y
J Hematol Oncol; 2022 Jun; 15(1):73. PubMed ID: 35659720
[TBL] [Abstract][Full Text] [Related]
20. Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema.
Lim HK; Kim KM; Jeong SY; Choi EK; Jung J
Integr Cancer Ther; 2017 Dec; 16(4):496-504. PubMed ID: 27151585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
